| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.58▲ | 1.60▼ | 1.61▼ | 1.60▼ | 1.78▼ |
| MA10 | 1.58▲ | 1.62▼ | 1.62▼ | 1.61▼ | 2.18▼ |
| MA20 | 1.59▲ | 1.63▼ | 1.62▼ | 1.68▼ | 2.41▼ |
| MA50 | 1.62▼ | 1.62▼ | 1.62▼ | 2.23▼ | 2.77▼ |
| MA100 | 1.63▼ | 1.63▼ | 1.64▼ | 2.41▼ | 2.99▼ |
| MA200 | 1.62▼ | 1.64▼ | 1.90▼ | 2.67▼ | 2.60▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.008▼ | -0.005▼ | 0.024▲ | -0.106▼ |
| RSI | 49.976▼ | 43.897▼ | 46.424▼ | 38.507▼ | 33.692▼ |
| STOCH | 53.241 | 14.241▼ | 46.173 | 29.641 | 13.462▼ |
| WILL %R | -11.111▲ | -70.370 | -70.370 | -66.667 | -90.361▼ |
| CCI | 52.000 | -127.472▼ | -113.390▼ | -40.528 | -128.748▼ |
|
Thursday, April 02, 2020 03:51 AM
Affimed (NASDAQ:AFMD) provides following updates in response to COVID-19 pandemic. The company has mandated a work-from-home policy for all employees not involved in preclinical research, and adjuste ...
|
|
Thursday, April 02, 2020 03:30 AM
Affimed N.V. (NASDAQ:AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight ...
|
|
Wednesday, April 01, 2020 08:56 PM
Affimed (NASDAQ:AFMD) is up 9.4% after noting the FDA granted orphan drug designation to its lead innate cell engager for treating T-cell lymphoma. AFM13, a CD30- and CD16A-binding innate cell engage ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/04/20 | 1.68 | 1.70 | 1.55 | 1.58 | 1,009,900 |
| 02/04/20 | 1.70 | 1.74 | 1.54 | 1.64 | 1,586,416 |
| 01/04/20 | 1.56 | 1.675 | 1.50 | 1.59 | 5,165,700 |
| 31/03/20 | 1.61 | 1.68 | 1.57 | 1.58 | 1,043,300 |
| 30/03/20 | 1.61 | 1.69 | 1.57 | 1.61 | 1,197,200 |
| 27/03/20 | 1.57 | 1.735 | 1.52 | 1.56 | 1,334,700 |
| 26/03/20 | 1.62 | 1.68 | 1.56 | 1.57 | 2,206,400 |
| 25/03/20 | 1.71 | 1.74 | 1.585 | 1.61 | 1,876,800 |
| 24/03/20 | 1.73 | 1.81 | 1.68 | 1.71 | 1,350,100 |
| 23/03/20 | 1.87 | 1.87 | 1.65 | 1.70 | 1,275,800 |
|
|
||||
|
|
||||
|
|